Snippet Search

Searching 11,550,396 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 922 matching articles

Results per page:

...  Mitomycin 
Synthesis, characterization and biological evaluation of 99mTc-labeled Mitomycin C
Synthesis, characterization and biological evaluation of 99mTc-labeled Mitomycin C
Bokhari, Tanveer Hussain; Akbar, Muhammad Usman; Roohi, Samina; Hina, Saira; Sohaib, Muhammad; Rizvi, Faheem Askari
-C is used for the treatment of different ...
... Hintergrund Die postoperative  Mitomycin 
Nicht muskelinvasives Urothelkarzinom der Harnblase
Nicht muskelinvasives Urothelkarzinom der Harnblase
Rehme, C.; Niedworok, C.; Rübben, H.; Dorp, F.
-Instillation nach TUR-B (transurethrale ...
... inhibitor, dorzolamide, in combination with  mitomycin 
Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich’s carcinoma grown in mice: role of thioredoxin-interacting protein
Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich’s carcinoma grown in mice: role of thioredoxin-interacting protein
Ali, Belal M.; Zaitone, Sawsan A.; Shouman, Samia A.; Moustafa, Yasser M.
C and to study the effect of these drugs on ...
... for its antimutagenic properties against  mitomycin 
In vitro and in vivo antimutagenic effects of DIG, a herbal preparation of Berberis vulgaris, Taraxacum officinale and Arctium lappa, against mitomycin C
In vitro and in vivo antimutagenic effects of DIG, a herbal preparation of Berberis vulgaris, Taraxacum officinale and Arctium lappa, against mitomycin C
Giorgio, C.; Boyer, L.; Meo, M.; Laurant, C.; Elias, R.; Ollivier, E.
C. ...
... intravesical regimen that includes both  mitomycin 
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
Hayne, Dickon; Stockler, Martin; McCombie, Steve P.; Chalasani, Venu; Long, Anne; Martin, Andrew; Sengupta, Shomik; Davis, Ian D.
and BCG. ...
... each for thiotepa, doxorubicin, and  mitomycin 
Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor
Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor
Rosoff, James S.; Keane, Thomas E.
. ...
... contained in the classical aminoquinones (  mitomycin 
DNA Damaging Drugs
DNA Damaging Drugs
Weber, Georg F.
C, porfiromycin, KW-2149, streptonigrin), ...
... of sequential intravesical gemcitabine and  mitomycin 
Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial
Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial
Jayant, Kumar; Kumar, Santosh; Singh, Shrawan kumar; Agrawal, Swati; Agrawal, Rajendra
C with ...
... Results Under the effect of  mitomycin 
VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth
VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth
Li, Xiuli; Gu, Fang; Niu, Chenguang; Wang, Yuanfen; Liu, Zhongyu; Li, Na; Pan, Bing; He, Dan; Kong, Jian; Zhang, Shaobo; Wang, Xu; Yao, Yuanqing; Zheng, Lemin
C, we identify a new member of VEGFxxxb ...
... intraperitoneal chemotherapy (HIPEC) with  mitomycin 
Cisplatin/doxorubicin/mitomycin
Cisplatin/doxorubicin/mitomycin
[ ...
... endoscopic bougie dilatation and topical  mitomycin 
Management Experience of Subglottic Stenosis by Endoscopic Bougie Dilatation with Mitomycin C and Review of Literature: Case Series
Management Experience of Subglottic Stenosis by Endoscopic Bougie Dilatation with Mitomycin C and Review of Literature: Case Series
Liew, Y. T.; Yong, D. J.; Somasundran, M.; Lum, C. L.
C. ...
... been well described in GCT patients [22].  Mitomycin 
Contribution of Chemotherapy to the Toxicity of Pelvic Irradiation
Contribution of Chemotherapy to the Toxicity of Pelvic Irradiation
Sehdev, Amikar; W. Marsh, R.
C ...
... second most frequently used substance was  mitomycin 
The Historical Perspective of Gastric Cancer
The Historical Perspective of Gastric Cancer
Rogy, Michael A.; Bünger, Marius A.
C, isolated from populations of ...
... of S. aureus to fluoroquinolones and  mitomycin 
Activation of the SOS response increases the frequency of small colony variants
Activation of the SOS response increases the frequency of small colony variants
Vestergaard, Martin; Paulander, Wilhelm; Ingmer, Hanne
C increased the frequency of gentamicin ...
... was done, followed by application of  mitomycin 
Nasopharyngeal Stenosis: A Rare Radiotherapy Complication
Nasopharyngeal Stenosis: A Rare Radiotherapy Complication
Nitassi, Sophia; Kissi, Mehdi; Rkain, Ilham; Benbouzid, Anas; Oujilal, Abdelillah; Essakalli, Leila
-C without stenting. ...
... treatments identified include imiquimod,  mitomycin 
A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring
A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring
Sidgwick, G. P.; McGeorge, D.; Bayat, A.
C and plant extracts such as onion extract, ...
... one or more chemotherapeutics (e.g.,  mitomycin 
Transarterial chemoembolization (TACE) for colorectal liver metastases—current status and critical review
Transarterial chemoembolization (TACE) for colorectal liver metastases—current status and critical review
Massmann, Alexander; Rodt, Thomas; Marquardt, Steffen; Seidel, Roland; Thomas, Katrina; Wacker, Frank; Richter, Götz M.; Kauczor, Hans U.; Bücker, Arno; Pereira, Philippe L.; Sommer, Christof M.
C, gemcitabine, and/or irinotecan) can be ...
... tumors were not balanced in the two arms,  mitomycin 
New Trials
New Trials
Costantini, Barbara; Fagotti, Anna; Montori, Giulia; Coccolini, Federico; Ansaloni, Luca; Scambia, Giovanni
-C only was used for perfusate during ...
... Ausdehnung eine adjuvante topische  Mitomycin 
Adjuvante Therapie und interdisziplinäre Nachsorge des Bindehautmelanoms
Adjuvante Therapie und interdisziplinäre Nachsorge des Bindehautmelanoms
Heindl, L.M.; Koch, K.R.; Schlaak, M.; Mauch, C.; Cursiefen, C.
-C-Therapie oder Protonenbestrahlung. ...
... woman developed dry eye syndrome following  mitomycin 
Mitomycin
Mitomycin
[ ...
... and nonproliferation conditions following  mitomycin 
Dynamic changes of nuclear RNA foci in proliferating DM1 cells
Dynamic changes of nuclear RNA foci in proliferating DM1 cells
Xia, Guangbin; Ashizawa, Tetsuo
C treatment. ...
... Tumor cell sensitivity to oxaliplatin, 5FU,  mitomycin 
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
Bjersand, Kathrine; Mahteme, Haile; Sundström Poromaa, Inger; Andréasson, Håkan; Graf, Wilhelm; Larsson, Rolf; Nygren, Peter
C, doxorubicin, irinotecan, and cisplatin ...
... in the culture supernatant of 56609 after  mitomycin 
Identification of three extra-chromosomal replicons in Leptospira pathogenic strain and development of new shuttle vectors
Identification of three extra-chromosomal replicons in Leptospira pathogenic strain and development of new shuttle vectors
Zhu, Weinan; Wang, Jin; Zhu, Yongzhang; Tang, Biao; Zhang, Yunyi; He, Ping; Zhang, Yan; Liu, Boyu; Guo, Xiaokui; Zhao, Guoping; Qin, Jinhong
C induction, and lcp3, which contained ...
... patients aged 42−59 years who developed  mitomycin 
Mitomycin
Mitomycin
-induced pulmonary veno-occlusive disease ...
... a drug eruption during treatment with  mitomycin 
Mitomycin
Mitomycin
for superficial bladder cancer. ...